Simulations Plus (Simulations Plus) ROCE %

: 9.96% (As of Feb. 2024)

View and export this data going back to 1997. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Simulations Plus's annualized ROCE % for the quarter that ended in Feb. 2024 was 9.96%.

Simulations Plus ROCE % Historical Data

The historical data trend for Simulations Plus's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Simulations Plus Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

ROCE %

Get a 7-Day Free Trial

26.77

11.20

6.70

8.66

6.59

Simulations Plus Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
ROCE %	Get a 7-Day Free Trial															9.23	9.72	6.24	2.19	9.96

Simulations Plus ROCE % Calculation

Simulations Plus's annualized ROCE % for the fiscal year that ended in Aug. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Aug. 2023 )		(A: Aug. 2022 )		(A: Aug. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Aug. 2023 )		(A: Aug. 2022 )		(A: Aug. 2023 )
	=	11.695	/	( ( (188.382 - 7.735)	+	(186.101 - 11.987) )	/ 2 )
	=	11.695	/	( (180.647	+	174.114)	/ 2 )
	=	11.695	/	177.3805
	=	6.59 %

Simulations Plus's ROCE % of for the quarter that ended in Feb. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Feb. 2024 )		(Q: Nov. 2023 )		(Q: Feb. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Feb. 2024 )		(Q: Nov. 2023 )		(Q: Feb. 2024 )
	=	17.768	/	( ( (185.778 - 8.588)	+	(193.973 - 14.528) )	/ 2 )
	=	17.768	/	( ( 177.19	+	179.445 )	/ 2 )
	=	17.768	/	178.3175
	=	9.96 %

(1) Note: The EBIT data used here is four times the quarterly (Feb. 2024) EBIT data.

Simulations Plus (NAS:SLP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Simulations Plus ROCE % Related Terms

Thank you for viewing the detailed overview of Simulations Plus's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Simulations Plus (Simulations Plus) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Simulations Plus Inc (NAS:SLP) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

42505 Tenth Street West, Lancaster, CA, USA, 93534-7059

Website

https://www.simulations-plus.com

Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. It generates maximum revenue from the software segment.

Executives

John Kenneth Paglia	director	746 GRABLE PLACE, NEWBURY PARK CA 91320
Walter S Woltosz	director, 10 percent owner, officer: Chairman and CEO	42505 10TH ST. WEST, LANCASTER CA 93534
Dibella John Anthony Ii	officer: Division President	42505 10TH STREET WEST, LANCASTER CA 93534
Lisa Lavange	director	42505 10TH ST., WEST, LANCASTER CA 93534
Steven Chang	officer: President, Immunetrics	42505 10TH STREET WEST, LANCASTER CA 15203
Shawn Oconnor	officer: Chief Executive Officer	42505 10TH STREET WEST, LANCASTER CA 93534-7059
Jill Fiedler-kelly	officer: President, Cognigen Division	42505 10TH STREET WEST, LANCASTER CA 93534
Brett Howell	officer: President, DILIsym Division	42505 10TH STREET WEST, LANCASTER CA 93534
William W Frederick	officer: CFO	C/O SIMULATIONS PLUS, INC., 42505 10TH STREET WEST, LANCASTER CA 93534
Daniel L Weiner	director	800 WEST EL CAMINO REAL, SUITE 200, MOUNTAIN VIEW CA 94040
Sharlene Evans	director	42505 10TH STREET WEST, LANCASTER CA 93534
Nguyen Nguyen	officer: VP of Human Resources	42505 TENTH STREET WEST, LANCASTER CA 93534
David L. Ralph	director	42505 10TH STREET WEST, LANCASTER CA 93534
John Robert Kneisel	officer: CFO	42505 10TH STREET WEST, LANCASTER CA 93534
Grasela Thaddeus Henry Jr	director, officer: President	1780 WEHRLE DRIVE SUITE 110, BUFFALO NY 14221